Literature DB >> 383014

In vitro model simulating the form of exposure of bacteria to antimicrobial drugs encountered in infection.

M J Al-Asadi, D Greenwood, F O'Grady.   

Abstract

A new model, which is designed to investigate the in vitro activity of antibiotics as a function of different concentration-time curves, is described. The antibiotic is allowed to diffuse through a membrane into a bacterial culture until a peak level is reached; the antibiotic is then removed by flow-assisted back diffusion. With this arrangement it is possible to expose bacteria to a changing concentration of drug while maintaining a constant volume of bacterial culture. Preliminary studies were carried out to investigate the response of a strain of Escherichia coli to gentamicin. The results indicate that bacteria surviving exposure to concentrations of gentamicin similar to those obtained during therapy may exhibit an increase in resistance to the antibiotic.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 383014      PMCID: PMC352792          DOI: 10.1128/AAC.16.1.77

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Animal models in the assessment of antimicrobial agents.

Authors:  F O'Grady
Journal:  J Antimicrob Chemother       Date:  1976-03       Impact factor: 5.790

Review 2.  An in vitro model of the urinary bladder.

Authors:  D Greenwood; F O'Grady
Journal:  J Antimicrob Chemother       Date:  1978-03       Impact factor: 5.790

3.  Specific and non-specific resistance to aminoglycosides in Escherichia coli.

Authors:  S L Mawer; D Greenwood
Journal:  J Clin Pathol       Date:  1978-01       Impact factor: 3.411

4.  A twelve channel bacterial growth monitoring system.

Authors:  I P Mackintosh; F O'Grady; D Greenwood; B W Watson; T C Crichton; R Piper; A Ferrer
Journal:  Biomed Eng       Date:  1973-12

5.  Infections in cancer patients. Results with gentamicin sulfate therapy.

Authors:  G P Bodey; E Middleman; T Umsawadi; V Rodriguez
Journal:  Cancer       Date:  1972-06       Impact factor: 6.860

6.  Aminoglycoside resistance due to mutation.

Authors:  D V Seal; J E Strangeways
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

7.  Bactericidal activity of cephalosporins in an in vitro model simulating serum levels.

Authors:  M Nishida; T Murakawa; T Kamimura; N Okada
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

8.  New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity.

Authors:  S Grasso; G Meinardi; I de Carneri; V Tamassia
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

  8 in total
  6 in total

1.  Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.

Authors:  E Löwdin; I Odenholt; S Bengtsson; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

2.  Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models.

Authors:  S Keil; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

3.  Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.

Authors:  J W Mouton; J G den Hollander
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

4.  Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model.

Authors:  I Haller
Journal:  Infection       Date:  1982       Impact factor: 3.553

5.  Antibacterial kinetics of ampicillin against Escherichia coli under simulated in vivo conditions.

Authors:  J E Fuglesang; T Bergan
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

6.  New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics.

Authors:  T Murakawa; H Sakamoto; T Hirose; M Nishida
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.